Literature DB >> 31274034

Targeting transpulmonary pressure to prevent ventilator-induced lung injury.

Luciano Gattinoni1, Lorenzo Giosa1, Matteo Bonifazi1, Iacopo Pasticci1, Mattia Busana1, Matteo Macri1, Federica Romitti1, Francesco Vassalli1, Michael Quintel1.   

Abstract

Introduction: Transpulmonary pressure (PL) is the pressure distending the lung. This pressure equals the stress which develops into the parenchyma at each insufflation and it depends, for a given airway pressure, on the relationship between the lung and the chest wall elastance: a given stress is associated to a given strain, therefor PL is strictly related to ventilator-induced lung injury (VILI). Insufficient knowledge and increased workload account for its limited use in the clinical setting: indeed, the current recommendations for protective ventilation still rely only on the pressures applied to the respiratory system in total (Plateau pressure), without a direct measurement of the real lung stress. Areas covered: We reviewed the significance, the assessment, the application and the limits of transpulmonary pressure in the clinical setting. Expert opinion: Transpulmonary pressure represents a physiologically sound safety limit for mechanical ventilation that should be measured and targeted at least in the most severe ARDS patients. Targeting transpulmonary pressure means 'personalizing' the ventilatory settings.

Entities:  

Keywords:  ARDS; VILI; esophageal pressure; mechanical ventilation; pleural pressure; stress; transpulmonary pressure

Mesh:

Year:  2019        PMID: 31274034     DOI: 10.1080/17476348.2019.1638767

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  8 in total

1.  Individualized PEEP to optimise respiratory mechanics during abdominal surgery: a pilot randomised controlled trial.

Authors:  Ana Fernandez-Bustamante; Juraj Sprung; Robert A Parker; Karsten Bartels; Toby N Weingarten; Carolina Kosour; B Taylor Thompson; Marcos F Vidal Melo
Journal:  Br J Anaesth       Date:  2020-07-16       Impact factor: 9.166

2.  Assessment of different computing methods of inspiratory transpulmonary pressure in patients with multiple mechanical problems.

Authors:  Kamil İnci; Nazlıhan Boyacı; İskender Kara; Gül Gürsel
Journal:  J Clin Monit Comput       Date:  2021-09-03       Impact factor: 1.977

3.  Transpulmonary pressure in SARS-CoV-2-associated acute respiratory distress syndrome: a single-center observational study.

Authors:  Severin Ramin; Jonathan Charbit; Geoffrey Dagod; Mehdi Girard; Samir Jaber; Xavier Capdevila
Journal:  Crit Care       Date:  2020-07-09       Impact factor: 9.097

4.  Effect of Deep Sedation on Mechanical Power in Moderate to Severe Acute Respiratory Distress Syndrome: A Prospective Self-Control Study.

Authors:  Yongpeng Xie; Lijuan Cao; Ying Qian; Hui Zheng; Kexi Liu; Xiaomin Li
Journal:  Biomed Res Int       Date:  2020-04-11       Impact factor: 3.411

5.  Mechanical power at a glance: a simple surrogate for volume-controlled ventilation.

Authors:  Lorenzo Giosa; Mattia Busana; Iacopo Pasticci; Matteo Bonifazi; Matteo Maria Macrì; Federica Romitti; Francesco Vassalli; Davide Chiumello; Michael Quintel; J J Marini; Luciano Gattinoni
Journal:  Intensive Care Med Exp       Date:  2019-11-27

6.  Bedside calculation of mechanical power during volume- and pressure-controlled mechanical ventilation.

Authors:  Davide Chiumello; Miriam Gotti; Mariateresa Guanziroli; Paolo Formenti; Michele Umbrello; Iacopo Pasticci; Giovanni Mistraletti; Mattia Busana
Journal:  Crit Care       Date:  2020-07-11       Impact factor: 9.097

7.  Development of a work of breathing scale and monitoring need of intubation in COVID-19 pneumonia.

Authors:  Mylene Apigo; Jeffrey Schechtman; Nyembezi Dhliwayo; Mohammed Al Tameemi; Raúl J Gazmuri
Journal:  Crit Care       Date:  2020-07-31       Impact factor: 9.097

8.  COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Authors:  Luciano Gattinoni; Davide Chiumello; Pietro Caironi; Mattia Busana; Federica Romitti; Luca Brazzi; Luigi Camporota
Journal:  Intensive Care Med       Date:  2020-04-14       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.